富煌钢构(002743) - 2023 Q1 - 季度财报

Financial Performance - The company's operating revenue for Q1 2023 was ¥1,262,099,801.44, representing a 23.09% increase compared to ¥1,025,325,914.46 in the same period last year[5] - Net profit attributable to shareholders was ¥19,037,082.71, up 35.27% from ¥14,072,905.88 year-on-year[5] - Basic and diluted earnings per share increased by 33.33% to ¥0.04 from ¥0.03 in the same period last year[5] - The net profit for the first quarter of 2023 was CNY 21,924,681.33, an increase of 51.3% compared to CNY 14,505,779.22 in the same period last year[20] - The operating profit for the first quarter was CNY 25,112,269.20, up 46.7% from CNY 17,115,113.40 year-on-year[20] - The total comprehensive income for the first quarter was CNY 21,924,681.33, an increase from CNY 14,505,779.22 year-on-year[21] Cash Flow and Liquidity - The net cash flow from operating activities decreased significantly by 87.39%, amounting to ¥10,452,897.89 compared to ¥82,896,510.40 in the previous year[5] - The cash flow from operating activities was CNY 10,452,897.89, a decrease of 87.4% from CNY 82,896,510.40 in the same quarter last year[24] - Cash and cash equivalents at the end of the period were CNY 349,484,673.64, down from CNY 480,908,272.92 at the end of the previous year[24] Assets and Liabilities - Total assets at the end of the reporting period were ¥10,855,490,278.29, a decrease of 1.83% from ¥11,057,947,034.50 at the end of the previous year[5] - Total liabilities decreased to RMB 7,657,856,201.81 from RMB 7,882,430,342.20, a reduction of approximately 2.8%[17] - The company's total liabilities increased, with notes payable rising by 38.92% to ¥1,414,937,649.09 from ¥1,018,555,822.10[8] - The company's cash and cash equivalents at the end of Q1 2023 amounted to RMB 662,072,397.26, slightly up from RMB 656,816,631.59 at the beginning of the year[14] Research and Development - The company's R&D expenses rose by 41.16% to ¥44,036,255.83, compared to ¥31,196,444.84 in the previous year, indicating increased investment in innovation[8] - Research and development expenses increased to CNY 44,036,255.83, a rise of 41.0% from CNY 31,196,444.84 in the previous year[20] Shareholder Information - The number of ordinary shareholders at the end of the reporting period was 22,995[10] - The company's equity attributable to shareholders increased to RMB 3,139,589,268.62 from RMB 3,118,859,483.04, showing a growth of about 0.7%[17] Future Outlook - Future outlook includes potential market expansion and new product development strategies, although specific figures were not disclosed in the current report[19]